Coprisjal restricts sale of coVID-19 "cure" drug
The Commission noted that the sale of azithromycin and hydroxychloroquine should be by prescription only
Azithromycin and hydroxychloroquine have been associated as a curative preventive treatment against COVID-19, which led to increases in their purchase.
For this reason, the Commission for the Protection of Health Risks in the State of Jalisco (Coprisjal) sent a circular to pharmacies and hospitals with a pharmacy to restrict the sale.
The unit further emphasized that there is currently no drug that cures or prevents COVID-19infection.
According to the circular, the sale of azithromycin and hydroxychloroquine,in all itspresentations and brands, must be done exclusively with a prescription,which will have to be retained.
This after considering evidence of likely abuse and harm to health by the free purchase, dispensing and consumption of these drugs.
Coprisjal emphasized that ingesting any over-the-counter medication poses a serious risk of poisoning.
"Self-medicating, in the case of antibiotics, can generate microbial resistance and weaken people's immunity. It doesn't prevent the disease, it's conducive," he stressed.
He added that there are antimalarial medications at risk of toxicity that can lead to cardiac arrest, muscle weakness and visual problems.
"These drugs are mistakenly perceived as safe treatment for disease (COVID-19), putting the health of those who consume them at risk without being under any medical care," Coprisjal stressed.
Azithromycin and hydroxychloroquines,reported, are prescribed for immunosuppressive diseases such as lupus, malaria and rheumatic disease,so their indiscriminate purchase can lead to people who actually require it, unable to achieve it.
Google translation from Informador.